Ide-cel Post Hematopoietic Cell Transplant
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 32 patients (estimated)
- Sponsors
- Memorial Sloan-Kettering Cancer Center
- Tags
- CAR T Cell, B-Cell Maturation Antigen (BCMA), Post-Allogeneic Stem Cell Transplant, Post-Autologous Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1292
- NCT Identifier
- NCT05393804
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.